首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Differentiation between radiation-induced brain injury and glioma recurrence using 3D pCASL and dynamic susceptibility contrast-enhanced perfusion-weighted imaging
【24h】

Differentiation between radiation-induced brain injury and glioma recurrence using 3D pCASL and dynamic susceptibility contrast-enhanced perfusion-weighted imaging

机译:使用3D PCASL和动态敏感性对比度增强灌注加权成像的辐射诱导脑损伤与胶质瘤复发的分化

获取原文
获取原文并翻译 | 示例
           

摘要

PurposeThis study was performed to validate the efficacy of three-dimensional pseudocontinuous arterial spin labeling (pCASL) compared with dynamic susceptibility contrast-enhanced perfusion-weighted imaging (DSC-PWI) in distinguishing radiation-induced brain injury from glioma recurrence in patients with glioma. MethodsBoth 3D pCASL and DSC-PWI were performed using a 3.0?Tesla scanner in 69 patients with previously resected and irradiated glioma who displayed newly developed abnormal contrast-enhanced lesions. The included patients were classified into a radiation-induced brain injury group (n?=?34) and a glioma recurrence group (n?=?35) based on subsequent pathologic analysis or clinical–radiological follow-up. Lesion perfusion parameter values (CBF and nCBF on pCASL, nrCBV and nrCBF on DSC-PWI) were measured and compared between the two groups using Student’sttest. Pearson correlation analysis was performed to evaluate the correlation between pCASL (CBF and nCBF) and DSC-PWI (nrCBV and nrCBF) values in the contrast-enhanced lesions and in the perifocal edema regions. ResultsFor the contrast-enhanced lesions, the CBF, nCBF, nrCBV, and nrCBF (29.46?±?15.08?ml/100?g/min, 1.11?±?0.50, 1.39?±?1.15, and 1.30?±?0.74) in the radiation-induced brain injury group were significantly lower than those (64.52?±?33.92?ml/100?g/min, 2.73?±?1.71, 3.39?±?2.12, and 3.20?±?1.95) in the glioma recurrence group (P?
机译:进行了目的研究以验证三维伪连续动脉旋转标记(PCASL)与动态敏感性对比增强灌注加权成像(DSC-PWI)相互鉴别脊髓灰瘤患者的辐射诱导的脑损伤。方法使用39例患有39名患者的39名患者进行3D PCAS1和DSC-PWI进行39例,以前切除和辐照的胶质瘤展示新出现的异常对比增强病变。将包括的患者分为辐射诱导的脑损伤基团(N?=Δ34)和基于随后的病理分析或临床放射学随访的胶质瘤复发基团(N?= 35)。测量病变灌注参数值(CBF和NCBF,在DSC-PWI上的PCASL,NRCBV和NRCBF),并使用Student'Test比较两组。进行Pearson相关性分析以评估对比度增强病变和周围水肿区中PCASL(CBF和NCBF)和DSC-PWI(NRCBV和NRCBF)值之间的相关性。结果对比增强病变,CBF,NCBF,NRCBV和NRCBF(29.46?±15.08?ML / 100?G / min,1.11?±α0.50,1.39?±α?1.15和1.30?±0.74)在辐射诱导的脑损伤小组中显着低于那些(64.52?±33.92?ml / 100?g / min,2.73?±1.71,3.39?±2.12和3.20?±1.95)复发群(P?<?0.001)。 CBF和NCBF在对比增强病变中表现出与NRCBV和NRCBF的强烈相关性。结论使用3D PCASL和DSC-PWI可以可靠地区分地区诱导的脑损伤和胶质瘤复发。无对比的3D PCASL是DSC-PWI的适用于术后放疗术后无胶质瘤患者的长期随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号